Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic

BACKGROUND: Older adults and immunocompromised individulas are often excluded from vaccine trials. AIM: We hypothesised that during the coronavirus disease 2019 (COVID-19) pandemic, the proportion of trials excluding these patients decreased. METHODS: Using the US Food and Drug Administration and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukan, Katrine, Pearce-Slade, Toby, Eiberg, Mads, Tinelli, Marco, Yahav, Dafna, Tuells, Jose, Epaulard, Olivier, Holler, Jon G., Roed, Casper, Søborg, Christian, Jensen, Jens-Ulrik Stæhr, Harboe, Zitta Barrella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080508/
https://www.ncbi.nlm.nih.gov/pubmed/37027085
http://dx.doi.org/10.1007/s40520-023-02380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080508/
https://www.ncbi.nlm.nih.gov/pubmed/37027085
http://dx.doi.org/10.1007/s40520-023-02380-4

Ejemplares similares